tiprankstipranks
Advertisement
Advertisement

BMY Stock Latest News

Bristol Myers price target raised to $71 from $66 at BofA
The FlyBristol Myers price target raised to $71 from $66 at BofA
2d ago
BMY
Bristol Myers price target raised to $59 from $54 at Cantor Fitzgerald
PremiumThe Fly
Bristol Myers price target raised to $59 from $54 at Cantor Fitzgerald
2d ago
BMY
Bristol Myers price target raised to $73 from $67 at JPMorgan
PremiumThe Fly
Bristol Myers price target raised to $73 from $67 at JPMorgan
2d ago
BMY
Bristol Myers price target raised to $75 from $72 at Guggenheim
PremiumThe Fly
Bristol Myers price target raised to $75 from $72 at Guggenheim
2d ago
BMY
Why is Biotech Stock Replimune (REPL) Soaring Over 120% Today?
PremiumMarket News
Why is Biotech Stock Replimune (REPL) Soaring Over 120% Today?
2d ago
BMY
REPL
Bristol Myers price target raised to $65 from $60 at Wells Fargo
PremiumThe FlyBristol Myers price target raised to $65 from $60 at Wells Fargo
2d ago
BMY
Bristol-Myers Squibb: Strong Q2 Beat, Intact Pipeline Support Buy Rating as Jason Gerberry Raises Price Target from $66 to $71
Premium
Ratings
Bristol-Myers Squibb: Strong Q2 Beat, Intact Pipeline Support Buy Rating as Jason Gerberry Raises Price Target from $66 to $71
2d ago
BMY
Bristol Myers Squibb Earnings Call Signals Growth Momentum
Premium
Company Announcements
Bristol Myers Squibb Earnings Call Signals Growth Momentum
2d ago
BMY
Bristol-Myers Squibb: Strong Quarter and Higher Eliquis Growth Outlook Offset by Legacy Declines and Pipeline Delays, Supporting Hold Rating
PremiumRatings
Bristol-Myers Squibb: Strong Quarter and Higher Eliquis Growth Outlook Offset by Legacy Declines and Pipeline Delays, Supporting Hold Rating
2d ago
BMY
Unusually active option classes on open July 30th
PremiumThe Fly
Unusually active option classes on open July 30th
3d ago
BMY
VXX
Morning Movers: Baxter surges following beat and raise report
PremiumThe Fly
Morning Movers: Baxter surges following beat and raise report
3d ago
MO
BAX
Bristol Myers Squibb Raises 2026 Revenue Outlook
PremiumCompany Announcements
Bristol Myers Squibb Raises 2026 Revenue Outlook
3d ago
8K
BMY
Bristol Myers says ‘committed’ to dividend
PremiumThe FlyBristol Myers says ‘committed’ to dividend
3d ago
BMY
Bristol Myers raises FY26 adjusted EPS view to $6.75-$7.00 from $6.05-$6.35
Premium
The Fly
Bristol Myers raises FY26 adjusted EPS view to $6.75-$7.00 from $6.05-$6.35
3d ago
BMY
Options Volatility and Implied Earnings Moves Today, July 30, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, July 30, 2026
3d ago
MA
MO
Bristol Myers reports Q2 adjusted EPS $2.04, consensus $1.60
PremiumThe Fly
Bristol Myers reports Q2 adjusted EPS $2.04, consensus $1.60
3d ago
BMY
These Are the Stocks Reporting Earnings Today – July 30, 2026
PremiumMarket News
These Are the Stocks Reporting Earnings Today – July 30, 2026
3d ago
MA
MO
Bristol-Myers Squibb: Market Perform Rating Reiterated with Unchanged $60 Price Target Amid Steady but Measured Growth Outlook
PremiumRatings
Bristol-Myers Squibb: Market Perform Rating Reiterated with Unchanged $60 Price Target Amid Steady but Measured Growth Outlook
5d ago
BMY
MapLight Therapeutics price target lowered to $24 from $43 at Canaccord
PremiumThe Fly
MapLight Therapeutics price target lowered to $24 from $43 at Canaccord
5d ago
BMY
MPLT
Is BMY a Buy, Before Earnings?
PremiumPre-EarningsIs BMY a Buy, Before Earnings?
5d ago
BMY
Options Volatility and Implied Earnings Moves This Week, July 27 – July 31, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, July 27 – July 31, 2026
6d ago
F
V
The Week That Was, The Week Ahead: Macro and Markets, July 26
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, July 26
7d ago
F
O

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >